FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: nasdaq:pgnx

Sort
E.g., 2013-06-20
E.g., 2013-06-20
Enter a comma separated list of user names.

Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focusing on the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.

MSHL, Marshall Edwards Inc.

** MSHL reported that the U.S. Patent and Trademark Office has issued a new patent, U.S. Patent No. 8,080,675, covering a number of the Company's isoflavone-based compounds, including lead oncology-drug candidates ME-143 and ME-344, and their pharmaceutical compositions. The patent is estimated to provide protection until March 2027.

Pages

ADVERTISE WITH US